APA (7th ed.) Citation

Sibbing, D., Blaha, M. J., Chawla, R., Lavalle-Cobo, A., Kishore, A., Lanas, A., . . . Shi, Z. Dual-pathway Inhibition with Low-dose Aspirin and Rivaroxaban versus Aspirin Monotherapy in Patients with Coronary Artery Disease and Peripheral Artery Disease: Systematic Literature Review and Meta-analysis. Radcliffe Medical Media.

Chicago Style (17th ed.) Citation

Sibbing, Dirk, et al. Dual-pathway Inhibition with Low-dose Aspirin and Rivaroxaban Versus Aspirin Monotherapy in Patients with Coronary Artery Disease and Peripheral Artery Disease: Systematic Literature Review and Meta-analysis. Radcliffe Medical Media.

MLA (9th ed.) Citation

Sibbing, Dirk, et al. Dual-pathway Inhibition with Low-dose Aspirin and Rivaroxaban Versus Aspirin Monotherapy in Patients with Coronary Artery Disease and Peripheral Artery Disease: Systematic Literature Review and Meta-analysis. Radcliffe Medical Media.